Behavioral effects of aminoadamantane class NMDA receptor antagonists on schedule-induced alcohol and self-administration of water in mice

Psychopharmacology

Volumn 187, Issue 4, 2006, Pages 424-434

  Escher, Tobie ^a   Call, Stanford B ^b   Blaha, Charles D ^b   Mittleman, Guy ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b University of Memphis   (United States)

Author keywords

Alcohol; Amantadine; Aminoadamantanes; Ethanol; Memantine; Mice; NMDA receptors; Schedule induced polydipsia

Indexed keywords

ALCOHOL; AMANTADINE; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; SODIUM CHLORIDE; WATER;

ADAPTATION; ALCOHOL ABUSE; ALCOHOL METABOLISM; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRINKING BEHAVIOR; DRUG SELF ADMINISTRATION; FLUID INTAKE; FOOD DEPRIVATION; LICKING; LOCOMOTION; MALE; MOUSE; NONHUMAN; POLYDIPSIA; PRIORITY JOURNAL;

ALCOHOL DRINKING; AMANTADINE; ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING; DRINKING BEHAVIOR; ETHANOL; EXCITATORY AMINO ACID ANTAGONISTS; LOCOMOTION; MALE; MEMANTINE; MICE; MICE, INBRED C57BL; RECEPTORS, N-METHYL-D-ASPARTATE; REINFORCEMENT SCHEDULE; SELF ADMINISTRATION;

EID: 33746864158     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-006-0465-5     Document Type: Article

References (79)

1. Alkana RL, Parker ES, Malcolm RD, Cohen HB, Birch H, Noble EP (1982) Interaction of apomorphine and amantadine with alcohol in men. Alcohol Clin Exp Res 6:403-411
2. Bisaga A, Evans SM (2003) Acute effects of memantine in combination with alcohol in moderate drinkers. Psychopharmacology 172:16-24
3. Bormann J (1989) Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels. Eur J Pharmacol 166:591-592
4. Boyce-Rustay J, Risinger FO (2003) Dopamine D3 receptor knockout mice and the motivational effects of alcohol. Pharmacol Biochem Behav 75:373-379
5. Braun AR, Laruelle M, Mouradian MM (1997) Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications. J Neural Transm 104:341-362
6. Brett LP, Levine S (1979) Schedule-induced polydipsia suppresses pituitary-adrenal activity in rat. J Comp Physiol Psychol 93:946-956
7. Brett LP, Levine S (1981) The pituitary-adrenal response to "minimized" schedule-induced drinking. Physiol Behav 26:152-158
8. Bubser M, Keseberg U, Notz PK, Schmidt WJ (1992) Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats. Eur J Pharmacol 229:75-82
9. Camarini R, Hodge CW (2004) Ethanol preexposure increases ethanol self-administration in C57BL/6J and DBA/2J mice. Pharmacol Biochem Behav 79:623-632
10. Camarini R, Mehmert KK, Hodge CW (2000) Effects of alcohol pre-exposure on alcohol self-administration in DBA/2J and C57BL/6 mice. Alcohol Clin Exp Res Suppl 24:16A
11. Clement HW, Grote C, Svensson L, Engel J, Zofel P, Wesemann W (1995) In vivo studies on the effects of memantine on dopamine metabolism in the striatum and n. accumbens of the rat. J Neural Transm Suppl 46:107-115
12. Crabbe JC, Belknap JK, Buck KJ (1994) Genetic animal models of alcohol and drug abuse. Science 264:1715-1723
13. Crum RM, Muntaner C, Eaton WW, Anthony JC (1995) Occupational stress and the risk of alcohol abuse and dependence. Alcohol Clin Ex Res 19:647-655
14. Dahchour A, De Witte P (2000) Ethanol and amino acids in the central nervous system: assessment of the pharmacological actions of acamprosate. Prog Neurobiol 60:343-362
15. Dahchour A, DeWitte P, Bolo N, Nedelec J-F, Muzet M, Durbin P, Macher JP (1998) Central effects of acamprosate: part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in alcohol withdrawn rats. Psychiatry Res 82:107-114
16. Dai X, Thavundayil J, Gianoulakis C (2002) Response of the hypothalamic-pituitary-adrenal axis to stress in the absence and presence of ethanol in subjects at high and low risk of alcoholism. Neuropsychopharmacology 27:442-452
17. Dantzer R, Terlouw C, Mormede P, Le Moal M (1988) Schedule-induced polydipsia experience decreases plasma corticosterone levels but increases plasma prolactin levels. Physiol Behav 43:275-279
18. Danysz W, Essmann U, Bresink I, Wilke R (1994) Glutamate antagonists have different effects on spontaneous locomotor activity in rats. Pharmacol Biochem Behav 48:111-118
19. Danysz W, Parsons CG, Kornhuber J, Schmidt W, Quack G (1997) Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents - preclinical studies. Neurosci Biobehav Rev 21:455-468
20. De Leonibus E, Mele A, Oliverio A, Pert A (2001) Locomotor activity induced by the non-competitive N-methyl-D-aspartate antagonist, MK-801: role of nucleus accumbens efferent pathways. Neuroscience 104:105-116
21. Falk JL (1961) Production of polydipsia in normal rats by an intermittent food schedule. Science 133:195-196
22. Falk JL (1971) The nature and determinants of adjunctive behavior. Physiol Behav 6:577-588
23. Fisher A, Biggs CS, Starr MS (1998) Differential effects of NMDA and non-NMDA antagonists on the activity of aromatic L-amino acid decarboxylase activity in the nigrostriatal dopamine pathway of the rat. Brain Res 792:126-132
24. Fitzgerald LW, Nestler EJ (1995) Molecular and cellular adaptations in signal transduction pathways following ethanol exposure. Clin Neurosci 3:165-173
25. Geldenhuys WJ, Malan SF, Bloomquist JR, Marchand AP, Van der Schyf CJ (2005) Pharmacology and structure-activity relationships of bioactive polycyclic cage compounds: a focus on pentacycloundecane derivatives. Med Res Rev 25:21-48
26. Hayden FG, Minocha A, Spyker DA, Hoffman HE (1985) Comparative single-dose pharmacokinetics of amantadine hydrochloride and rimantadine hydrochloride in young and elderly adults. Antimicrob Agents Chemother 28:216-221
27. Hernandez-Avila CA, Oncken C, Van Kirk J, Wand G, Kranzler HR (2002) Adrenocorticotropin and cortisol responses to a naloxone challenge and risk of alcoholism. Biol Psychiatry 51:652-658
28. Hesselink HB, De-Boer AG, Breimer DD, Danysz W (1999) Dopamine release in the prefrontal cortex in response to memantine following sub-chronic NMDA receptor blockade with memantine: a microdialysis study in rats. J Neural Transm 106:803-818
29. Hoffman HE, Gaylord JC, Blasecki JW, Shalaby LM, Whitney CC (1988) Pharmacokinetics and metabolism of rimantadine hydrochloride in mice and dogs. Antimicrob Agents Chemother 32:1699-1704
30. Holter SM, Danysz W, Spanagel R (1996) Evidence for alcohol anti-craving properties of memantine. Eur J Pharmacol 314:R1-2
31. Huber TJ, Dietrich DE, Emrich HM (1999) Possible use of amandine in depression. Pharmacopsychiatry 32:47-55
32. Kornhuber J, Weller M (1997) Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy. Biol Psychiatry 41:135-144
33. Kornhuber J, Bormann J, Hubers M, Rusche K, Riederer P (1991) Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor gated ion channel: a human postmortem brain study. Eur J Pharmacol 206:297-300
34. Kornhuber J, Weller M, Schoppmeyer K, Riederer P (1994) Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties. J Neural Transm Suppl 43:91-104
35. Kotlinska J (2001) NMDA antagonists inhibit the development of alcohol dependence in rats. Pol J Pharmacol 53:47-50
36. Kushner MG, Sher KJ, Beitman BD (1990) The relation between alcohol problems and the anxiety disorders. Am J Psychiatry 147:685-695
37. Langenbucher J, Chung T, Morgenstern J, Labouvie E, Nathan PE, Bavly L (1997) Physiological alcohol dependence as a "specifier" of risk for medical problems and relapse liability in DSM-IV. J Stud Alcohol 58:341-350
38. Le A, Poulos CX, Quan B, Chow S (1993) The effects of selective blockade of delta and mu opiate receptors on alcohol consumption by C57BL/6 mice in a restricted access paradigm. Brain Res 630:330-332
39. Levine R, Levine S (1989) Role of the pituitary-adrenal hormones in the acquisition of schedule-induced polydipsia. Behav Neurosci 103:621-37
40. Lipton SA (2004) Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders. J Alzheimers Dis 6:S61-S74
41. Littleton J (1995) Acamprosate in alcohol dependence: how does it work? Addiction 90:1179-1188
42. Matsubayashi H, Swanson KL, Albuquerque EX (1997) Amantadine inhibits nicotinic acetylcholine receptor function in hippocampal neurons. J Pharmacol Exp Ther 281:834-844
43. Mele A, Wozniak KM, Hall FS, Pert A (1998) The role of striatal dopaminergic mechanisms in rotational behavior induced by phencyclidine and phencyclidine-like drugs. Psychopharmacology 135:107-118
44. Menon MK, Vivonia CA, Haddox VG (1984) Evidence for presynaptic antagonism by amantadine of indirectly acting central stimulants. Psychopharmacology 82:89-92
45. Messiha FS (1977) Modification of the central depressant action of alcohol by amantadine hydrochloride in the mouse. Proc West Pharmacol Soc 20:333-337
46. Messiha FS (1978) Antagonism of alcohol-evoked responses by amantadine: a possible clinical application. Pharmacol Biochem Behav 8:573-577
47. Micuda S, Mundlova L, Anzenbacherova E, Anzenbacher P, Chladek J, Fuksa L, Martinkova J (2004) Inhibitory effects of memantine on human cytochrome P450 activities: prediction of in vivo drug interactions. Eur J Pharmacol 60:583-589
48. Mirovsky Y, Yu YL, Wagner GC, Sekowski A, Goldberg M, Fisher H (1995) Novel synergistic treatment of ethanol withdrawal seizures in rats with dopamine and serotonin agonists. Alcohol Clin Exp Res 19:160-163
49. Mittleman G, Rosner AL, Schaub CL (1994) Polydipsia and dopamine: behavioral effects of dopamine D1 and D2 receptor agonists and antagonists. J Pharmacol Exp Ther 271:638-650
50. Mittleman G, Van Brunt CL, Matthews DB (2003) Schedule-induced alcohol self-administration in DBA/2J and C57BL/6J mice. Alcohol Clin Exp Res 27:918-925
51. Mizoguchi K, Yokoo H, Yoshida M, Tanaka T, Tanaka M (1994) Amantadine increases the extracellular dopamine levels in the striatum by re-uptake inhibition and by N-methyl-D-aspartate antagonism. Brain Res 662:255-258
52. Muller WE, Mutschler E, Riederer P (1995) Noncompetitive NMDA receptor antagonists with fast open-channel blocking kinetics and strong voltage-dependency as potential therapeutic agents for Alzheimer's dementia. Pharmacopsychiatry 28:113-124
53. Nuotto E, Mattila MJ (1984) Failure of amantadine and bromocriptine to counteract alcoholic inebriation in man. Acta Pharm Toxicol 55:168-173
54. Page G, Peeters M, Maloteaux JM, Hermans E (2000) Increased dopamine uptake in striatal synaptosomes after treatment of rats with amantadine. Eur J Pharmacol 403:75-80
55. Parsons CG, Quack G, Bresink I, Baran L, Przegalinski E, Kostowski W, Krzascik P, Hartmann S, Danysz W (1995) Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo. Neuropharmacology 34:1239-1258
56. Parsons CG, Danysz W, Quack G (1999) Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist - a review of preclinical data. Neuropharmacology 38:735-767
57. Peeters M, Page G, Maloteaux JM, Hermans E (2002) Hypersensitivity of dopamine transmission in the rat striatum after treatment with the NMDA receptor antagonist amantadine. Brain Res 949:32-41
58. Peeters M, Maloteaux J-M, Hermans E (2003) Distinct effects of amantadine and memantine on dopaminergic transmission in the rat striatum. Neurosci Lett 343:205-209
59. Periclou A, Ventura D, Rao N, Abromowitz W (2006) Pharmacokinetic study of memantine in healthy and renally impaired subjects. Clin Pharmacol Ther 79:134-143
60. Piasecki J, Koros E, Dyr W, Kostowski W, Danysz W, Bienkowski P (1998) Alcohol-reinforced behavior in rats: effects of uncompetitive NMDA receptor antagonist, memantine. Eur J Pharmacol 354:135-143
61. Pohorecky LA (1981) The interaction of alcohol and stress. A review. Neurosci Biobehav Rev 5:209-229
62. Quack G, Hesselink M, Danysz H, Spanagel R (1995) Microdialysis studies with amantadine and memantine on pharmacokinetics and effects on dopamine turnover. J Neural Transm Suppl 46:97-105
63. Risinger FO, Brown MM, Doan AM, Oakes RA (1998) Mouse strain differences in oral operant ethanol reinforcement under continuous access conditions. Alcohol Clin Exp Res 22:677-684
64. Rogawski MA (1993) Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines. Trends Pharmacol Sci 14:325-331
65. Roper TJ, Nieto J (1979) Schedule-induced drinking and other behavior in the rat, as a function of body weight deficit. Physiol Behav 23:673-678
66. Schmidt WJ, Kretschmer BD (1997) Behavioural pharmacology of glutamate receptors in the basal ganglia. Neurosci Biobehav Rev 21:381-392
67. Shearman E, Rossi S, Szasz B, Juranyi Z, Fallon S, Pomara N, Sershen H, Lajtha A (2006) Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study. Brain Res Bull 69:204-213
68. Shelton KL, Balster RL (1997) Effects of γ-aminobutyric acid agonists and N-Methyl-D-aspartate antagonists on a multiple schedule of alcohol and saccharin self-administration in rats. J Pharmacol Exp Ther 280:1250-1260
69. Smothers CT, Mrotek JJ, Lovinger DM (1997) Chronic ethanol exposure leads to a selective enhancement of N-methyl-D-aspartate receptor function in cultured hippocampal neurons. J Pharmacol Exp Ther 283:1214-1222
70. Spanagel R, Zieglgansberger W (1997) Anti-craving compounds for alcohol: new pharmacological tools to study addictive processes. Trends Pharmacol Sci 18:54-59
71. Spanagel R, Eilbacher B, Wilke R (1994) Memantine-induced dopamine release in the prefrontal cortex and striatum of the rat - a pharmacokinetic microdialysis study. Eur J Pharmacol 262:21-26
72. Starr MS, Starr BS (1995) Locomotor effects of amantadine in the mouse are not those of a typical glutamate antagonist. J Neural Transm Parkinson's Dis Dement Sect 9:31-43
73. Svensson A, Carlsson ML, Carlsson A (1995) Crucial role of the accumbens nucleus in the neurotransmitter interactions regulating motor control in mice. J Neural Transm Gen Sect 101:127-148
74. Tang M, Falk JL (1986) Alcohol polydipsic choice: effects of alternative fluid polydipsic history. Alcohol 3:361-365
75. Tazi A, Dantzer R, Mormede P, LeMoal M (1986) Effects of naloxone, â-endorphin and ACTH on acquisition of schedule-induced polydipsia. Psychopharmacology 85:87-91
76. Wand G, McCaul ME, Gotjen D, Reynolds J, Lee S (2001) Confirmation that offspring from families with alcohol-dependent individuals have greater hypothalamic-pituitary-adrenal axis activation induced by naloxone compared with offspring without a family history of alcohol dependence. Alcohol Clin Exp Res 25:1134-1139
77. Wayner MJ (2002) Craving for alcohol in the rat: adjunctive behavior and the lateral hypothalamus. Pharmacol Biochem Behav 73:27-43
78. Wenk GL, Danysz W, Mobley SL (1995) MK-801, memantine and amantadine show neuroprotective activity in the nucleus basalis magnocellularis. Eur J Pharmacol 293:267-270
79. Williams SL, Tang M, Falk JL (1992) Prior exposure to a running wheel and scheduled food attenuates polydipsia acquisition. Physiol Behav 52:481-483